The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-5-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)benzyl)-1,4-dioxepane-5-carboxylic acid ID: ALA2282521
PubChem CID: 76309039
Max Phase: Preclinical
Molecular Formula: C25H27NO6
Molecular Weight: 437.49
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1oc(-c2ccccc2)nc1CCOc1ccc(C[C@@]2(C(=O)O)CCOCCO2)cc1
Standard InChI: InChI=1S/C25H27NO6/c1-18-22(26-23(32-18)20-5-3-2-4-6-20)11-13-30-21-9-7-19(8-10-21)17-25(24(27)28)12-14-29-15-16-31-25/h2-10H,11-17H2,1H3,(H,27,28)/t25-/m1/s1
Standard InChI Key: QVOIEZBLTDUYGB-RUZDIDTESA-N
Molfile:
RDKit 2D
32 35 0 0 0 0 0 0 0 0999 V2000
26.0428 -15.7681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7398 -16.2078 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.8340 -17.0320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2599 -16.0426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2527 -17.6196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9874 -16.8257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4314 -17.5256 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.1884 -15.7780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1873 -16.6052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9020 -17.0181 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6185 -16.6047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6156 -15.7743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9002 -15.3652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3284 -15.3591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4726 -17.0171 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.7585 -16.6041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7584 -15.3557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4733 -15.7675 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.7575 -14.5307 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.0437 -17.0160 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3840 -16.5211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3968 -15.6941 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6164 -15.4269 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.1210 -16.0864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5954 -16.7613 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.0717 -15.2196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2961 -16.0786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8941 -15.3576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0699 -15.3494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6496 -16.0605 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0598 -16.7813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8826 -16.7860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
1 4 1 0
3 5 1 0
4 6 1 0
5 7 1 0
6 7 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
12 14 1 0
14 1 1 0
9 15 1 0
15 16 1 0
1 17 1 1
17 18 1 0
17 19 2 0
16 20 1 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 1 0
24 25 2 0
25 21 1 0
22 26 1 0
24 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 437.49Molecular Weight (Monoisotopic): 437.1838AlogP: 4.07#Rotatable Bonds: 8Polar Surface Area: 91.02Molecular Species: ACIDHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.60CX Basic pKa: 0.93CX LogP: 3.80CX LogD: 0.45Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.57Np Likeness Score: -0.68
References 1. Verma RK, Kumar V, Ghosh P, Wadhwa LK. (2013) 3D-QSAR study of tyrosine and propanoic acid derivatives as PPAR/ dual agonists using CoMSIA, 22 (1): [10.1007/s00044-012-0003-4 ]